Image pharmaphorum Editor News GSK strengthens core prescription business with Sin hire In a drive to boost its search for innovative products worldwide, GlaxoSmithKline (GSK) has hired Kevin Sin from Roche. News Pharma playing catch-up as GDPR deadline nears Pharma will need to change its culture White Papers Sponsored Thinking niche: the challenge of pharma's focus on small pat... With the pharma industry putting the ‘blockbuster’ age behind it and moving into meeting needs across myriad niche disease areas, what is the impact and therefore change of requirement in terms of News FDA rejects Pfizer Herceptin biosimilar, wants technical inf... A Pfizer-produced biosimilar of Roche’s blockbuster breast cancer drug, Herceptin, has been rejected by US regulators. Load more results
News GSK strengthens core prescription business with Sin hire In a drive to boost its search for innovative products worldwide, GlaxoSmithKline (GSK) has hired Kevin Sin from Roche.
White Papers Sponsored Thinking niche: the challenge of pharma's focus on small pat... With the pharma industry putting the ‘blockbuster’ age behind it and moving into meeting needs across myriad niche disease areas, what is the impact and therefore change of requirement in terms of
News FDA rejects Pfizer Herceptin biosimilar, wants technical inf... A Pfizer-produced biosimilar of Roche’s blockbuster breast cancer drug, Herceptin, has been rejected by US regulators.
News MSD, Daiichi pull filing for lung cancer candidate I-DXd MSD and Daiichi Sankyo's regulatory efforts for their ADCs for cancer have stuttered again, with a withdrawn filing for lung cancer candidate I-DXd.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
